샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777377

세계의 IVD 수탁 제조 시장

IVD Contract Manufacturing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 378 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 IVD 수탁 제조 시장은 2030년까지 295억 달러에 도달

2024년에 167억 달러로 추정되는 IVD 수탁 제조 세계 시장은 2024-2030년간 CAGR 10.0%로 성장하여 2030년에는 295억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 소모품은 CAGR 8.5%를 나타내고, 분석 기간 종료시에는 172억 달러에 이를 것으로 예측됩니다. 기기 부문의 성장률은 분석 기간중 CAGR 12.4%로 추정됩니다.

미국 시장은 추정 45억 달러, 중국은 CAGR13.4%로 성장 예측

미국의 IVD 수탁 제조 시장은 2024년에 45억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 60억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 13.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 7.3%와 8.7%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 7.8%를 나타낼 전망입니다.

IVD 수탁 제조 시장 - 주요 동향과 촉진요인 정리

체외진단용 의약품(IVD)의 위탁생산은 전 세계 진단산업에 필수적인 요소로 자리 잡았으며, 의료기기 제조업체는 시약, 소모품, 진단기기의 제조를 전문 제3자 제조업체에 위탁할 수 있게 되었습니다. 신속하고 정확한 진단 솔루션에 대한 수요가 증가함에 따라 IVD 기업들은 위탁생산기관(CMO)이나 개발-제조수탁기관(CDMO)을 활용하여 생산 규모 확대, 비용 최적화, 시장 진입을 가속화하려는 움직임이 가속화되고 있습니다. 분자진단, 면역분석, 현장진단(POCT), 동반진단약물의 복잡성으로 인해 고품질의 규제 준수 위탁생산 솔루션에 대한 필요성이 더욱 커지고 있습니다.

정밀의료, 디지털 진단, 실험실 검사 자동화의 확대로 체외진단 의약품 산업이 재편되고 있으며, 분석법 개발, 시약 처방, 기기 조립의 아웃소싱이 확대되고 있습니다. 의료 서비스 제공업체들은 보다 신속하고 비용 효율적이며 확장 가능한 검사 솔루션을 원하고 있으며, 빠르게 변화하는 시장에서 경쟁력을 유지하고자 하는 기업들에게 IVD 위탁생산은 전략적으로 필수적인 요소가 되고 있습니다.

기술 발전이 IVD 수탁 제조를 어떻게 강화하고 있는가?

IVD 위탁생산 분야에서는 생산 효율성, 품질 관리, 확장성을 향상시키기 위한 기술적 진보가 눈에 띄게 진행되고 있습니다. 가장 중요한 기술 혁신 중 하나는 제조 공정에 자동화와 로봇 공학을 통합하는 것입니다. 자동화 시스템은 현재 액체 취급, 시약 분주, 하이슬-풋 분석 제조에 사용되어 인적 오류를 줄이고 공정의 일관성을 높이고 있습니다. 이는 특히 정확성과 재현성이 매우 중요한 분자진단 키트, 측면 흐름 분석, 면역 분석에 유용합니다.

또 다른 큰 혁신은 체외진단용 의약품 시약과 분석용 성분의 제조에 일회용 바이오프로세싱 기술을 도입한 것입니다. 일회용 바이오리액터, 마이크로플루이딕스 칩, 사전 충전된 시약 카트리지를 사용하여 무균성, 오염 관리, 배치 간 일관성을 개선하여 수탁 제조를 보다 효율적이고 비용 효율적으로 만듭니다. 또한, 3D 프린팅과 미세 가공의 발전으로 진단 기기의 신속한 시제품 제작과 맞춤화가 가능해져 차세대 IVD 솔루션의 개발 주기가 빨라지고 있습니다.

분자진단과 개인 맞춤형 의료의 부상으로 맞춤형 분석법 개발 및 바이오마커 기반 검사 제조의 개선이 이루어지고 있습니다. IVD 위탁생산 업체들은 현재 하이스루풋 시퀀싱(NGS), 크리스퍼 기반 분석, 디지털 PCR(dPCR) 플랫폼을 활용하여 종양학, 감염성 질환, 유전성 질환에 특화된 진단 솔루션을 개발하고 있습니다. 또한, 인공지능(AI)과 머신러닝을 품질관리 프로세스에 접목하여 위탁생산 시설의 실시간 모니터링, 예지보전, 배치 최적화를 개선하고 있습니다.

IVD 위탁생산의 성장을 가속하는 시장 동향은?

몇 가지 주요 트렌드가 IVD 수탁 제조 산업을 형성하고 있으며, 아웃소싱의 확대와 기술 혁신을 촉진하고 있습니다. 가장 중요한 트렌드 중 하나는 현장 검사(POCT)와 분산형 진단에 대한 수요 증가입니다. 전통적인 실험실 기반 검사에서 휴대용, 신속하고 사용자 친화적인 진단 솔루션으로의 전환은 측면 유동성 분석, 미세 유체 검사 스트립, 휴대용 분자진단 의약품 위탁 생산의 급격한 증가로 이어졌습니다. 질병의 조기 발견과 원격 의료를 중시하는 전 세계적인 노력으로 IVD 기업들은 확장 가능하고 고품질의 제조에 정통한 전문 CMO에 POCT 제조를 위탁하고 있습니다.

또 다른 큰 트렌드는 정밀의료와 표적치료제의 등장에 따른 분자진단약과 동반진단약의 확대입니다. 제약사 및 바이오테크놀러지 기업들은 유전자 및 바이오마커 프로파일링에 기반한 맞춤형 치료법 선택을 가능하게 하는 동반진단제(CDx)를 개발하기 위해 체외진단제 제조업체와의 협력을 강화하고 있습니다. 이에 따라 PCR 기반, 차세대 시퀀싱(NGS), CRISPR 대응 진단 시약을 상업적 규모로 생산할 수 있는 고도로 전문화된 위탁생산 서비스에 대한 니즈가 높아지고 있습니다.

IVD 제조에 대한 규제가 복잡해지면서 기업들은 수탁 제조 솔루션으로 눈을 돌리고 있습니다. 진단 기기에 대한 FDA, EMA, ISO 13485의 요구사항이 강화됨에 따라, 많은 기업들이 규제에 대한 전문 지식, 검증된 제조 라인, 우수 제조 기준(GMP)을 준수하는 시설을 갖춘 숙련된 CDMO와 협력하고 있습니다. 생산 아웃소싱을 통해 IVD 기업은 규제 당국의 승인을 신속히 처리하고, 컴플라이언스 리스크를 줄이며, 세계 시장에서 일관된 품질 관리를 보장할 수 있습니다.

또한, 공급망 최적화와 비용 절감의 압력으로 인해 체외진단 의약품 기업들은 원재료 조달, 시약 조제, 기기 조립을 조달 네트워크가 구축되어 있고 비용 효율적인 생산 능력을 갖춘 CMO에 위탁하고 있습니다. 세계 공급망의 혼란이 가중되는 가운데, 제조업체들은 안정적인 제품 공급을 위해 현지 생산, 이중 조달 전략, 유연한 제조 능력을 제공하는 계약 파트너를 찾고 있습니다.

IVD 위탁생산 시장의 성장 원동력은?

IVD 위탁생산 시장은 신속 진단에 대한 수요 증가, 헬스케어 아웃소싱 트렌드, 진단 기술 발전 등 몇 가지 주요 성장 촉진요인에 의해 빠르게 성장하고 있습니다. 시장 성장을 이끄는 주요 요인 중 하나는 감염성 질환, 종양 바이오마커, 유전성 질환의 검출을 위한 분자-면역 진단 검사가 광범위하게 채택되고 있다는 점입니다. 인구 고령화, 만성질환 증가, 세계 팬데믹 대비를 배경으로 고처리량, 고신뢰성, 고비용의 진단 솔루션에 대한 수요가 급증하고 있으며, IVD 기업들은 대규모 생산을 위해 위탁생산에 의존하고 있습니다.

또 다른 큰 성장 요인은 중소규모의 바이오테크놀러지 기업의 위탁생산 채택이 증가하고 있다는 점입니다. 많은 스타트업과 신생 진단약 기업들은 자체 제조 역량이 부족하여 CMO를 활용하여 제조 규모를 확대하고, 규제 문제를 극복하고, 시장 진입을 가속화하고 있습니다. 경험이 풍부한 IVD 수탁 제조업체와 협력함으로써, 이들 기업은 고품질의 GMP 준수 제조를 보장하는 동시에 연구와 혁신에 집중할 수 있습니다.

AI와 디지털 전환의 역할이 커지면서 맞춤형 위탁생산 솔루션의 필요성이 더욱 커지고 있습니다. AI를 활용한 진단약, 클라우드 기반 검사 관리 플랫폼, 웨어러블 바이오센서가 보급됨에 따라 IVD 제조업체는 스마트 제조, 자동 품질관리, 실시간 분석에 능통한 위탁생산 파트너를 필요로 하고 있습니다. 이러한 차세대 제조 솔루션은 기업의 생산 효율화, 검사 정확도 향상, 확장성 강화를 돕고 있습니다.

또한, IVD 제조 기지의 지리적 확장이 시장 성장을 가속하고 있습니다. 미국, 유럽, 일본이 지속적으로 진단약 혁신을 주도하고 있는 가운데, 중국, 인도, 한국, 싱가포르 등 아시아태평양 국가들은 비용 우위, 숙련된 노동력, 바이오테크놀러지 및 의료기술에 대한 투자를 지원하는 유리한 정부 정책으로 인해 주요 위탁생산 국가로 부상하고 있습니다. 주요 위탁생산지로 부상하고 있습니다. 많은 세계 IVD 기업들이 낮은 제조 비용, 강력한 인프라, 대량 생산 능력의 혜택을 누리기 위해 아시아태평양으로 생산 기지를 이전하고 있습니다.

마지막으로, 지속가능성과 친환경 제조에 대한 관심이 높아지면서 IVD 위탁생산의 상황이 바뀌고 있습니다. 기업들은 폐기물을 최소화하고, 이산화탄소 배출량을 줄이고, 환경 규제를 준수하기 위해 친환경 제조 기술, 생분해성 테스트 부품, 에너지 효율이 높은 제조 공정을 모색하고 있습니다. 진단약 제조업체와 의료 서비스 제공업체에게 지속가능성이 중요한 과제로 떠오르고 있습니다.

부문

유형(소모품, 기기), 기술(면역측정, 임상화학, 분자진단, 미생물학, 혈액학, 응고·지혈, 기타), 서비스(제조, 어세이 개발, 기타)

조사 대상 기업 예

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing(GRAM)
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.01

Global IVD Contract Manufacturing Market to Reach US$29.5 Billion by 2030

The global market for IVD Contract Manufacturing estimated at US$16.7 Billion in the year 2024, is expected to reach US$29.5 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Equipment segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 13.4% CAGR

The IVD Contract Manufacturing market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

IVD Contract Manufacturing Market - Key Trends & Drivers Summarized

In-vitro diagnostics (IVD) contract manufacturing has become an essential part of the global diagnostic industry, enabling medical device companies to outsource the production of reagents, consumables, and diagnostic instruments to specialized third-party manufacturers. With the rising demand for rapid and accurate diagnostic solutions, IVD companies are increasingly turning to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) to scale production, optimize costs, and accelerate market entry. The growing complexity of molecular diagnostics, immunoassays, point-of-care testing (POCT), and companion diagnostics has further fueled the need for high-quality, regulatory-compliant contract manufacturing solutions.

The expansion of precision medicine, digital diagnostics, and automation in laboratory testing is reshaping the IVD landscape, leading to greater outsourcing of assay development, reagent formulation, and device assembly. With healthcare providers demanding faster, cost-effective, and scalable testing solutions, IVD contract manufacturing is becoming a strategic necessity for companies looking to stay competitive in a rapidly evolving market.

How Are Technological Advancements Enhancing IVD Contract Manufacturing?

The IVD contract manufacturing sector is experiencing significant technological advancements aimed at improving production efficiency, quality control, and scalability. One of the most critical innovations is the integration of automation and robotics into manufacturing workflows. Automated systems are now being used for liquid handling, reagent dispensing, and high-throughput assay production, reducing human error and enhancing process consistency. This is particularly beneficial for molecular diagnostic kits, lateral flow assays, and immunoassays, where precision and reproducibility are crucial.

Another major breakthrough is the adoption of single-use bioprocessing technologies for the manufacturing of IVD reagents and assay components. The use of disposable bioreactors, microfluidic chips, and pre-filled reagent cartridges has improved sterility, contamination control, and batch-to-batch consistency, making contract manufacturing more efficient and cost-effective. Additionally, advances in 3D printing and microfabrication are enabling the rapid prototyping and customization of diagnostic devices, accelerating the development cycle for next-generation IVD solutions.

The rise of molecular diagnostics and personalized medicine has also led to improvements in custom assay development and biomarker-based test manufacturing. IVD contract manufacturers are now utilizing high-throughput sequencing (NGS), CRISPR-based assays, and digital PCR (dPCR) platforms to develop specialized diagnostic solutions tailored to oncology, infectious diseases, and genetic disorders. Moreover, the incorporation of artificial intelligence (AI) and machine learning into quality control processes is improving real-time monitoring, predictive maintenance, and batch optimization in contract manufacturing facilities.

What Market Trends Are Driving the Growth of IVD Contract Manufacturing?

Several key trends are shaping the IVD contract manufacturing industry, driving increased outsourcing and technological innovation. One of the most significant trends is the growing demand for point-of-care testing (POCT) and decentralized diagnostics. The shift from traditional laboratory-based testing to portable, rapid, and user-friendly diagnostic solutions has led to a surge in contract manufacturing partnerships for lateral flow assays, microfluidic test strips, and handheld molecular diagnostics. With global health initiatives emphasizing early disease detection and remote healthcare, IVD companies are outsourcing POCT production to specialized CMOs with expertise in scalable, high-quality manufacturing.

Another major trend is the expansion of molecular and companion diagnostics in response to the rise of precision medicine and targeted therapies. Pharmaceutical companies and biotech firms are increasingly collaborating with IVD manufacturers to develop companion diagnostics (CDx) that enable personalized treatment selection based on genetic and biomarker profiling. This has fueled the need for highly specialized contract manufacturing services that can produce PCR-based, next-generation sequencing (NGS), and CRISPR-enabled diagnostic assays at commercial scale.

The increasing regulatory complexity in IVD manufacturing is also driving companies toward outsourced production solutions. With stricter FDA, EMA, and ISO 13485 requirements for diagnostic devices, many companies are partnering with experienced CDMOs that have established regulatory expertise, validated production lines, and Good Manufacturing Practice (GMP)-compliant facilities. By outsourcing production, IVD firms can accelerate regulatory approvals, reduce compliance risks, and ensure consistent quality control across global markets.

Additionally, supply chain optimization and cost reduction pressures are leading IVD companies to outsource raw material sourcing, reagent formulation, and device assembly to CMOs with well-established procurement networks and cost-efficient production capabilities. With the rise of global supply chain disruptions, manufacturers are seeking contract partners that offer localized production, dual-sourcing strategies, and flexible manufacturing capacities to ensure uninterrupted product availability.

What Is Driving the Growth of the IVD Contract Manufacturing Market?

The IVD contract manufacturing market is expanding rapidly due to several key growth drivers, including increased demand for rapid diagnostics, outsourcing trends in healthcare, and advancements in diagnostic technology. One of the primary factors propelling market growth is the widespread adoption of molecular and immunodiagnostic tests in the detection of infectious diseases, oncology biomarkers, and genetic disorders. With an aging population, rising prevalence of chronic diseases, and global pandemic preparedness, the need for high-throughput, reliable, and cost-effective diagnostic solutions has surged, leading IVD companies to rely on contract manufacturing for large-scale production.

Another major growth driver is the rising adoption of contract manufacturing by small and mid-sized biotech firms. Many startups and emerging diagnostic companies lack in-house manufacturing capabilities and instead leverage CMOs to scale up production, navigate regulatory challenges, and accelerate market entry. By partnering with experienced IVD contract manufacturers, these companies can focus on research and innovation while ensuring high-quality, GMP-compliant production.

The increasing role of AI and digital transformation in diagnostics is also fueling the need for customized contract manufacturing solutions. As AI-powered diagnostics, cloud-based test management platforms, and wearable biosensors gain traction, IVD manufacturers require contract production partners with expertise in smart manufacturing, automated quality control, and real-time analytics. These next-generation manufacturing solutions are helping companies streamline production, improve test accuracy, and enhance scalability.

Additionally, the geographic expansion of IVD manufacturing hubs is driving market growth. While the U.S., Europe, and Japan continue to lead in diagnostic innovation, countries in Asia-Pacific (China, India, South Korea, and Singapore) are emerging as key contract manufacturing destinations due to their cost advantages, skilled labor force, and favorable government policies supporting biotech and medtech investments. Many global IVD companies are shifting manufacturing operations to Asia-Pacific to benefit from lower production costs, strong infrastructure, and high-volume manufacturing capabilities.

Lastly, the increasing focus on sustainability and green manufacturing is reshaping the IVD contract manufacturing landscape. Companies are exploring eco-friendly production techniques, biodegradable test components, and energy-efficient manufacturing processes to minimize waste, reduce carbon footprints, and comply with environmental regulations. As sustainability becomes a key consideration for diagnostic manufacturers and healthcare providers,

SCOPE OF STUDY:

The report analyzes the IVD Contract Manufacturing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Consumables, Equipment); Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others); Service (Manufacturing, Assay Development, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing (GRAM)
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • IVD Contract Manufacturing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • OEM Outsourcing Strategies Accelerate Demand for End-to-End IVD Contract Manufacturing Services
    • Rising Pressure to Reduce Time-to-Market Drives Partnerships With Agile IVD CMOs
    • Surge in POC, Rapid, and Home Diagnostics Expands Need for Scalable, Flexible Manufacturing Capacity
    • Demand for OEM-Integrated Design-to-Scale Manufacturing Models Strengthens Business Case for CDMOs
    • Regulatory Complexity Across Global Markets Spurs Need for cGMP- and ISO-13485-Certified IVD Manufacturers
    • Growth in Molecular Diagnostics and PCR Platforms Boosts Demand for Specialized Assay and Cartridge Manufacturing
    • OEM Focus on Core Competency Retention Drives Strategic Outsourcing of Reagent and Consumable Production
    • Increasing Importance of Disposable Cassette and Microfluidic Device Production Fuels Market Differentiation
    • Rising Investment in Companion Diagnostics and Personalized Medicine Expands Scope of IVD CMO Engagements
    • Adoption of Digital Health and Remote Monitoring Platforms Drives Integration of IVD Hardware-Software Assemblies
    • Biotech and Start-Up Diagnostics Firms Leverage CMOs for Pilot-Through-Commercial Scaling
    • Emerging Need for Multiplex and Multi-Pathogen Test Manufacturing Supports Assay Customization Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World IVD Contract Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Assay Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제